|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Reduction in the carrying amount of right-of-use assets | |||||
| Amortization of deferred contract acquisition costs | |||||
| Accretion of discount on marketable investments | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| Amortization of discount and issuance costs on convertible senior notes | |||||
| Gain on early extinguishment of debt | |||||
| Impairment charge of an equity investment | |||||
| Impairment charge related to closure of operating lease facilities | |||||
| Interest on finance lease obligations | |||||
| Deferred taxes - excluding tax benefit from acquisition | |||||
| Deferred taxes - tax benefit from acquisition | |||||
| Change in fair value of contingent consideration | |||||
| Payment of contingent consideration liability in excess of acquisition-date fair value | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Deferred contract acquisition costs | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued and other current liabilities | |||||
| Deferred revenue | |||||
| Other long-term liabilities (including non-current portions of operating and finance lease liabilities) | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable investments | |||||
| Proceeds from sales of marketable investments | |||||
| Proceeds from maturities of marketable investments | |||||
| Purchases of property and equipment | |||||
| Capitalization of internal-use software development costs | |||||
| Payments of initial direct lease costs | |||||
| Cash paid for an equity investment in a privately-held company | |||||
| Cash paid to acquire Acqueon Inc. | |||||
| Acqueon Inc. | |||||
| Total cash paid to acquire Acqueon Inc. | |||||
| Cash settlement to acquire Aceyus, Inc. | |||||
| Aceyus, Inc. | |||||
| Total cash settlement to acquire Aceyus, Inc. | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of 2029 convertible senior notes | |||||
| Payment of debt issuance costs | |||||
| Payments for capped call transactions associated with the 2029 convertible senior notes | |||||
| Repurchase of a portion of 2025 convertible senior notes | |||||
| Convertible Senior Notes, Due 2023 | |||||
| Convertible Senior Notes, Due 2025 | |||||
| Total repurchase of a portion of 2025 convertible senior notes | |||||
| Repayments of outstanding | |||||
| Convertible Senior Notes, Due 2023 | |||||
| Convertible Senior Notes, Due 2025 | |||||
| Total repayments of outstanding | |||||
| Cash received from the settlement at maturity of the outstanding capped calls associated with the 2023 convertible senior notes | |||||
| Convertible Senior Notes, Due 2023 | |||||
| Convertible Senior Notes, Due 2025 | |||||
| Total cash received from the settlement at maturity of the outstanding capped calls associated with the 2023 convertible senior notes | |||||
| Cash received from partial termination of capped calls associated with the 2025 convertible senior notes | |||||
| Proceeds from exercise of common stock options | |||||
| Proceeds from sale of common stock under ESPP | |||||
| Payment of employee taxes related to vested RSUs | |||||
| Payment of contingent consideration liability up to acquisition-date fair value | |||||
| Cash paid for repurchase of the Company's common stock | |||||
| Payment of holdbacks related to acquisitions | |||||
| Payments of finance leases | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash: | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosures of cash flow data: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Equipment purchased and unpaid at period-end | |||||
| Capitalization of leasehold improvement through non-cash lease incentive | |||||
| Acquisition and related transaction costs accrued at period-end | |||||
| Stock-based compensation included in capitalized software development costs | |||||
| Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Consolidated Balance Sheets - Beginning of Period: | |||||
| Cash and cash equivalents | |||||
| Restricted cash in other assets | |||||
Loading...